National Bank of Canada
IONS icon

National Bank of Canada’s Ionis Pharmaceuticals IONS Stock Holding History

National Bank of Canada’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-80
Closed -$3.75K – 2903
2024
Q2 		$3.75K Hold
80
– – ﹤0.01% 2319
2024
Q1 		$3.13K Buy
+80
New +$3.81K ﹤0.01% 2393
2023
Q1 		– Sell
-60,895
Closed -$2.3M – 2786
2022
Q4 		$2.3M Buy
60,895
+9,175
+18% +$386K 0.01% 844
2022
Q3 		$2.29M Buy
+51,720
New +$2.18M 0.01% 752
2022
Q1 		– Sell
-70,000
Closed -$2.13M – 2936
2021
Q4 		$2.13M Buy
+70,000
New +$2.2M 0.01% 802

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

National Bank of Canada's IONS Position: Q3 2024 in Review

National Bank of Canada sold out of Ionis Pharmaceuticals (IONS) in Q3 2024, closing a stake of 80 shares — an estimated $3.75K sold.

National Bank of Canada first reported a position in IONS in Q4 2021 and held it in 5 quarters. The position peaked at $2.3M in Q4 2022. 354 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • National Bank of Canada reported no remaining Ionis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • National Bank of Canada sold 80 Ionis Pharmaceuticals shares in Q3 2024, an estimated $3.75K.
  • National Bank of Canada first reported a position in Ionis Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • National Bank of Canada's Ionis Pharmaceuticals position peaked at $2.3M in Q4 2022.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on National Bank of Canada's 13F filing for Q3 2024, filed 12 Nov 2024.